Table 2.

Multivariable Cox models of risk factors for detection of multiple viruses

Covariate≥2 viruses≥3 viruses≥4 viruses*
aHR (95% CI)aHR (95% CI)aHR (95% CI)
Age ≤21 y   2.65 (1.46-4.81) 
Male 1.18 (1.04-1.33)‡   
White    
CMV donor or recipient positive 2.47 (1.91-3.19) 3.10 (1.95-4.94)  
Donor related 0.93 (0.81-1.07) 1.00 (0.80-1.25)  
HCT comorbidity index    
 Low Ref Ref 
 Intermediate 1.03 (0.86-1.24) 1.64 (1.22-2.22) 
 High 1.07 (0.90-1.28) 1.13 (0.83-1.53) 
Myeloablative conditioning  1.36 (1.11-1.67)  
HCT type    
 HLA-matched Ref Ref Ref 
 HLA-mismatched 2.03 (1.75-2.37) 3.32 (2.64-4.18) 7.36 (4.13-13.1) 
 Cord blood 2.60 (2.16-3.14) 3.29 (2.46-4.40) 3.45 (1.62-7.36) 
Acute GVHD grades 3-4 2.14 (1.54-2.97)   
Covariate≥2 viruses≥3 viruses≥4 viruses*
aHR (95% CI)aHR (95% CI)aHR (95% CI)
Age ≤21 y   2.65 (1.46-4.81) 
Male 1.18 (1.04-1.33)‡   
White    
CMV donor or recipient positive 2.47 (1.91-3.19) 3.10 (1.95-4.94)  
Donor related 0.93 (0.81-1.07) 1.00 (0.80-1.25)  
HCT comorbidity index    
 Low Ref Ref 
 Intermediate 1.03 (0.86-1.24) 1.64 (1.22-2.22) 
 High 1.07 (0.90-1.28) 1.13 (0.83-1.53) 
Myeloablative conditioning  1.36 (1.11-1.67)  
HCT type    
 HLA-matched Ref Ref Ref 
 HLA-mismatched 2.03 (1.75-2.37) 3.32 (2.64-4.18) 7.36 (4.13-13.1) 
 Cord blood 2.60 (2.16-3.14) 3.29 (2.46-4.40) 3.45 (1.62-7.36) 
Acute GVHD grades 3-4 2.14 (1.54-2.97)   

Ref, reference.

*

This model supported only 2 variables because of limited events. Myeloablative conditioning was also significant after adjustment for HCT type: aHR, 4.64; 95% CI, <0.001.

P ≤ .001; ‡P ≤ .01.

or Create an Account

Close Modal
Close Modal